Aave founder pushes DeFi Uber strategy after CLARITY vote
Stani Kulechov proposed an adoption path for DeFi 46 minutes after the Senate rejected cloture on the CLARITY Act.
Yuna · Sep 17, 2026 · 1 min
CryptoSlate reports that the Senate failed to pass cloture for H.R. 3633, the CLARITY Act. By 2:19 p.m. Eastern time on Sept. 15, the tally stood at 49-50. Because cloture requires three-fifths support, the bill could not proceed immediately to the full floor, although the outcome was not a final vote on the legislation. Bitcoin prices fell below $76,000 after the rejection.
Approximately 46 minutes later, Aave founder Stani Kulechov posted on X. He argued that DeFi has grown too significant to overlook. Kulechov described this trajectory as an "Uber path" for broader adoption.
Aave’s consumer application offers self-custodial accounts with an option for lost-device recovery. In this structure, encrypted private-key data is split between CoinCover and Aave. Users regain access only after passing biometric checks and a one-time-password verification.
The protocol maintains a distinction between open-source infrastructure and consumer-facing services. Aave Labs develops software and interfaces for the Aave Protocol, a system the company neither owns nor controls. Aave Horizon aggregates stablecoin liquidity for institutional borrowers who use tokenized securities as collateral.
Asset issuers control wallet allowlists and verify investors for these collateralized loans. LlamaRisk performs asset due diligence and suggests loan-to-value ratios. Chainlink supplies onchain net-asset-value validation for the overall architecture.
Source: CryptoSlate
This story was produced by StreamSage's AI newsroom. Not financial advice.
More stories
- Sequans sells final 314 Bitcoin to end treasury strategy
The French chipmaker once held over 3,200 BTC but now reports zero crypto holdings and no outstanding debt beyond research obligations.
- Ecobank commits $2.6 billion to women and agriculture
CEO Jeremy Awori announced the plan in Lome, including a $2 billion allocation for the Ellevate by Ecobank program.
- Novo Nordisk signs $1 billion licensing deal with Nanexa
The Danish pharma major secured exclusive global rights to Nanexa's peptide delivery platform for obesity and cardiometabolic conditions.
- Best Buy cuts service transfers with AI support tools
The retailer said transfer rates dropped and more calls were resolved without a human, while development timelines for new tools shortened.